共 50 条
- [28] Use of Basal-Bolus Subcutaneous Insulin in the Initial Management of Mild to Moderate Diabetic Ketoacidosis is Safe in Type 1 Diabetes HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 1): : 76 - 77
- [30] Clinical Impact of GLP-1 receptor agonists in veterans receiving basal-bolus insulin PHARMACOTHERAPY, 2022, 42 (01): : 45 - 52